Context Therapeutics Inc [NASDAQ: CNTX] traded at a high on Friday, posting a 3.23 gain after which it closed the day’ session at $1.01.
The results of the trading session contributed to over 259944 shares changing hands. Over the past one week, the price volatility of Context Therapeutics Inc stands at 10.65% while the volatility over the past one month is 14.28%.
The market cap for CNTX stock reached $75.75 million, with 75.00 million shares outstanding and 44.51 million shares in the current float. Compared to the average trading volume of 547.63K shares, CNTX reached a trading volume of 259944 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Context Therapeutics Inc [CNTX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CNTX shares is $6.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CNTX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JMP Securities have made an estimate for Context Therapeutics Inc shares, keeping their opinion on the stock as Mkt Outperform, with their previous recommendation back on January 08, 2025. While these analysts kept the previous recommendation, D. Boral Capital raised their target price to Buy. The new note on the price target was released on November 25, 2024, representing the official price target for Context Therapeutics Inc stock. Previously, the target price had yet another raise to $4.50, while Piper Sandler analysts kept a Overweight rating on CNTX stock.
The Average True Range (ATR) for Context Therapeutics Inc is set at 0.14 The Price to Book ratio for the last quarter was 0.90, with the Price to Cash per share for the same quarter was set at 1.13.
How has CNTX stock performed recently?
Context Therapeutics Inc [CNTX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.48. With this latest performance, CNTX shares dropped by -25.74% in over the last four-week period, additionally sinking by -52.80% over the last 6 months – not to mention a drop of -6.05% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CNTX stock in for the last two-week period is set at 37.74, with the RSI for the last a single of trading hit 39.03, and the three-weeks RSI is set at 37.16 for Context Therapeutics Inc [CNTX]. The present Moving Average for the last 50 days of trading for this stock 1.4296, while it was recorded at 0.9977 for the last single week of trading, and 1.8528 for the last 200 days.
Context Therapeutics Inc [CNTX]: Deeper insight into the fundamentals
Context Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 36.91 and a Current Ratio set at 36.91.
Insider trade positions for Context Therapeutics Inc [CNTX]
There are presently around $76.40%, or 77.52%% of CNTX stock, in the hands of institutional investors. The top three institutional holders of CNTX stocks are: GREAT POINT PARTNERS LLC with ownership of 7.42 million shares, which is approximately 13.4999%. AVIDITY PARTNERS MANAGEMENT LP, holding 7.42 million shares of the stock with an approximate value of $$14.88 million in CNTX stocks shares; and AVIDITY PARTNERS MANAGEMENT LP, currently with $$14.88 million in CNTX stock with ownership which is approximately 13.4999%.
